Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of disability and low quality of life. One in every three people suffering from MDD ...
Compared with no antidepressant use, there was a significantly reduced risk of non-exudative AMD and exudative AMD with use of SSRIs, SNRIs, or tricyclic antidepressants. Depression and AMD share ...
Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results